AN2 Therapeutics, Inc. Common Stock (ANTX)
AN2 Therapeutics, Inc. Common Stock (ANTX) has a 15-report earnings history dating back to May 10, 2022. Its average absolute post-earnings move is ±9.39%, and 46.7% of those reactions were positive. Its largest post-earnings gain was +64.54% (Aug 11, 2022) and its largest decline was -9.32% (May 11, 2026).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
15
Avg Abs. Movement
±9.39%
Positive %
46.7%
Negative %
53.3%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ☽ POST | $4.54 | $4.80 | $4.72 | 20,491 | -9.32% | open_in_new |
| Mar 17, 2026 | ☽ POST | $4.73 | $5.05 | $5.00 | 9,943 | -7.69% | open_in_new |
| Nov 12, 2025 | ☽ POST | $1.20 | $1.20 | $1.20 | 110 | +0% | open_in_new |
| Mar 25, 2025 | ☽ POST | $1.50 | $1.50 | $1.50 | 789 | +3.68% | open_in_new |
| Nov 13, 2024 | ☽ POST | $1.05 | $1.05 | $1.00 | 53,700 | +1.5% | open_in_new |
| Aug 13, 2024 | ☽ POST | $1.11 | $1.12 | $1.08 | 5,888 | -1.85% | open_in_new |
| May 14, 2024 | ☽ POST | $2.37 | $2.37 | $2.29 | 1,391 | -1.09% | open_in_new |
| Mar 28, 2024 | ☽ POST | $3.23 | $3.36 | $3.31 | 2,126 | +13.42% | open_in_new |
| Nov 09, 2023 | ☽ POST | $14.86 | $15.37 | $15.37 | 952 | -5.66% | open_in_new |
| Aug 10, 2023 | ☽ POST | $8.15 | $8.35 | $8.35 | 2,956 | +0% | open_in_new |
| May 11, 2023 | ☽ POST | $5.15 | $5.29 | $5.18 | 1,749 | -2.12% | open_in_new |
| Mar 29, 2023 | ☽ POST | $9.79 | $9.82 | $9.82 | 267 | -2.55% | open_in_new |
| Nov 09, 2022 | ☽ POST | $15.50 | $15.57 | $15.46 | 748 | -5.17% | open_in_new |
| Aug 11, 2022 | ☽ POST | $11.33 | $11.82 | $11.76 | 1,924 | +64.54% | open_in_new |
| May 10, 2022 | ☽ POST | $16.34 | $16.58 | $14.00 | 8,979 | +22.32% | open_in_new |
Earnings Count
15
Total earnings in dataset
Avg Abs. Movement
±9.39%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
6 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260609 | open_in_new SEC.gov |
| 8-K | 20260604 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| CORRESP | 20260416 | open_in_new SEC.gov |
| UPLOAD | 20260415 | open_in_new SEC.gov |
Frequently asked about ANTX earnings
How much does ANTX stock move after earnings? expand_more
Over 15 reports, ANTX has moved an average of ±9.39% the session after earnings, closing higher 46.7% of the time.
What was ANTX's biggest post-earnings move? expand_more
ANTX's largest post-earnings gain on record was +64.54% on Aug 11, 2022, and its largest decline was -9.32% on May 11, 2026.
Where can I find AN2 Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of AN2 Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right